Things Not Often Taught in School: Embracing Vulnerable Populations in Ambulatory Care
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
Activity Overview
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience
Learning Objectives
After completing this activity, the learner should be able to…
1.) Define vulnerable patient populations
2.) List strategies for initiating or sustaining a practice serving vulnerable patient populations
3.) Discuss available resources to aid providers in caring for vulnerable patient populations
4.) Identify mechanisms to prepare the pharmacy workforce to work with vulnerable patient populations
Faculty
Cassie Heffern, PharmD, BCACP
Ambulatory Care Pharmacy Specialist/PGY2 Director
CoxHealth – Springfield, MO
Alex R. Mills, PharmD, BCACP, AAHIVP (He/Him/His)
Assistant Professor of Pharmacy Practice (HIV, LGBTQ+ Health)
University of Mississippi School of Pharmacy - Jackson Campus
Co-Director, Center for Gender and Sexual Minority Health
Clinical Pharmacist, Director of Clinical Operations - TEAM Clinic
University of Mississippi Medical Center
Jackson, Mississippi
Shirley Bonanni, PharmD, BCPS
Assistant Director, Clinical Services
Advanced Clinical Pharmacy Specialist – Family Medicine
Director, PGY1 Pharmacy Residency
Thomas Jefferson University Hospital
Philadelphia, PA
Moderator
Margie E. Padilla, PharmD, CDCES, BCACP
Clinical Associate Professor/Interprofessional Education Coordinator
Health-Focused Interprofessional Education Community of Practice Co-Advocate
Faculty, Border Biomedical Research Center
Department of Pharmacy Practice and Clinical Sciences
University of Texas at El Paso School of Pharmacy
El Paso, TX 79968
Relevant Financial Relationship Disclosure
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CPE activity.